Alternatives
Alternatives to Ro
Ro scores 68/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
Ro at a glance
- Semaglutide
- $348/moBrand Wegovy pen from $199, plus the $149 monthly membership
- Tirzepatide
- $448/moBrand Zepbound KwikPen from $299, plus the $149 monthly membership
- Coverage
- Multi-state
- Brand-name GLP-1s
- Yes
- Oral option
- Yes
- Pricing verified
- October 2026
7 of the 8 programs below list semaglutide for less than Ro's $348 a month. 7 of the 8 list tirzepatide for less than its $448 a month.
Ro sells only brand-name GLP-1s, from a $149 pill to a $199 Wegovy pen and a $299 Zepbound KwikPen, and each one needs a Ro Body membership of $74 to $149 a month on top.
Best for: People who want FDA-approved Wegovy, Zepbound or a GLP-1 pill, help checking insurance coverage, and a membership that handles dose changes and side effects.
What Ro does well
- Brand-name only: the Wegovy pill and Foundayo pill from $149 a month, the Wegovy pen from $199 and the Zepbound KwikPen from $299
- Every medication price is published by dose before you sign up, so you can see what the higher doses cost
- The first month of membership is $39, refunded if you aren't eligible for a GLP-1
- Prepaying the membership lowers it to $99, $89 or $74 a month on three, six or twelve months
- Ro will check your insurance coverage, and the membership covers on-demand provider support, side-effect care and dose adjustments
Why readers look for an alternative
- Two separate charges: medication is billed apart from the membership, so the Wegovy pen starts at $348 a month all-in on the monthly plan
- The $199 Wegovy pen price covers only the 0.25 mg and 0.5 mg doses; from 1 mg it is $349, and Zepbound rises to $399 at 5 mg and $449 above that
- No compounded option, so nothing here costs less than the brand-name cash prices
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Ro: $249/mo less for semaglutide · $299/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
- 02C66/ 100Index
Luvo Health
PartnerLuvo charges $209 every four weeks for compounded semaglutide and $249 for tirzepatide, with half off the first delivery and brand-name Ozempic or Zepbound available.
- Sema
- $209 per 4 weeksInjection, compounded
- Tirz
- $249 per 4 weeksInjection, compounded
- Coverage
- Multi-state
- Brand
- Yes
Compared with Ro: $139/mo less for semaglutide · $199/mo less for tirzepatide
- 03C69/ 100Index
TRYM Health
TRYM Health offers compounded semaglutide and tirzepatide with flat month-to-month prices and optional prepaid supplies.
- Sema
- $150/moMonth-to-month, all doses, compounded
- Tirz
- $180/moMonth-to-month, all doses, compounded
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Ro: $198/mo less for semaglutide · $268/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
Regulatory note: the FDA issued a warning letter to TRYM Health, Inc. dba TRYM Health in September 2025. We still list and link to TRYM Health; you should know the letter is on the public record before you decide.
- 04C69/ 100Index
InstaRX
InstaRX advertises compounded semaglutide and tirzepatide from $265 monthly with twelve months prepaid. Its terms include the $45 consultation fee in the monthly price.
- Sema
- $265/moStarting average (12-month prepayment, compounded)
- Tirz
- $265/moStarting average (12-month prepayment, compounded)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Ro: $83/mo less for semaglutide · $183/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
- 05C69/ 100Index
NexLife
NexLife is a LegitScript-certified compounded-GLP-1 and longevity telehealth platform under medical director Adam Kennah, M.D..
- Sema
- $139/moAll doses, monthly plan, compounded; $132/mo on a 3-month plan, $125/mo on 6 months, $119/mo on 12 months
- Tirz
- $169/moAll doses, monthly plan, compounded; $159/mo on a 3-month plan, $149/mo on 6 months, $139/mo on 12 months
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Ro: $209/mo less for semaglutide · $279/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
Regulatory note: the FDA issued a warning letter to Nexlife Inc. dba Nexlife in June 2026. We still list and link to NexLife; you should know the letter is on the public record before you decide.
- 06C69/ 100Index
RENN Health
RENN Health offers virtual semaglutide and tirzepatide programs with ongoing rates of $249 and $299 a month, six named pharmacy partners, and billing details to confirm before enrollment.
- Sema
- $249/moOngoing program rate; confirm billing and formulation
- Tirz
- $299/moOngoing program rate; confirm billing and formulation
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Ro: compounded only, no brand-name GLP-1s · no oral option
- 07C69/ 100Index
SexyMD
SexyMD offers compounded semaglutide and tirzepatide injections with Monthly Flex renewal prices of $299 and $399, following introductory first-month prices of $179 and $279.
- Sema
- $299/moMonthly Flex renewal (compounded; first month $179)
- Tirz
- $399/moMonthly Flex renewal (compounded; first month $279)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Ro: $49/mo less for semaglutide · $49/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
- 08C69/ 100Index
Voxy
Voxy charges $175 a month for compounded semaglutide and $225 for tirzepatide, all-in and month to month.
- Sema
- $175/moCompounded, billed monthly; $99/mo on a 12-month plan
- Tirz
- $225/moCompounded, billed monthly; $135/mo on a 12-month plan
- Coverage
- Not published
- Brand
- Compounded
Compared with Ro: $173/mo less for semaglutide · $223/mo less for tirzepatide · compounded only, no brand-name GLP-1s · no oral option
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.